Related references
Note: Only part of the references are listed.UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells
Yu Xiong et al.
BIOSCIENCE REPORTS (2019)
Ovarian Cancer: An Integrated Review
Christine Stewart et al.
SEMINARS IN ONCOLOGY NURSING (2019)
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Stephanie Lheureux et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer
Ki Hong Nam et al.
BMC CANCER (2019)
New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
Shang-Hung Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Regulating the CCNB1 gene can affect cell proliferation and apoptosis in pituitary adenomas and activate epithelial-to-mesenchymal transition
Bin Li et al.
ONCOLOGY LETTERS (2019)
SIRT5 Promotes Cisplatin Resistance in Ovarian Cancer by Suppressing DNA Damage in a ROS-Dependent Manner via Regulation of the Nrf2/HO-1 Pathway
Xiaodan Sun et al.
FRONTIERS IN ONCOLOGY (2019)
Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds
Yvonne Ziegler et al.
NPJ BREAST CANCER (2019)
FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1
Na Chai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
TOP2A induces malignant character of pancreatic cancer through activating beta-catenin signaling pathway
Yao-fei Pei et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Maintenance treatment of recurrent ovarian cancer: Is it ready for prime time?
Paul DiSilvestro et al.
CANCER TREATMENT REVIEWS (2018)
Prognostic factors in epithelial ovarian cancer: A population-based study
Lin-Chau Chang et al.
PLOS ONE (2018)
Expression and functional characterization of FOXM1 in non-small cell lung cancer
Yan Zhang et al.
ONCOTARGETS AND THERAPY (2018)
Honokiol is a FOXM1 antagonist
Marianna Halasi et al.
CELL DEATH & DISEASE (2018)
Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation
Harish N. Vasudevan et al.
CELL REPORTS (2018)
Regulation of the master regulator FOXM1 in cancer
Guo-Bin Liao et al.
CELL COMMUNICATION AND SIGNALING (2018)
FoxM1 Promotes Cell Proliferation, Invasion, and Stem Cell Properties in Nasopharyngeal Carcinoma
Weiren Luo et al.
FRONTIERS IN ONCOLOGY (2018)
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
Renata A. Tassi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas
David Milewski et al.
PLOS GENETICS (2017)
Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death
Liang Guo et al.
CELL CYCLE (2017)
FOXM1 in Cancer: Interactions and Vulnerabilities
Andrei L. Gartel
CANCER RESEARCH (2017)
Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression
Akira Kurosaki et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Rosmarinic Acid Methyl Ester Inhibits LPS-Induced NO Production via Suppression of MyD88-Dependent and -Independent Pathways and Induction of HO-1 in RAW 264.7 Cells
Yangkang So et al.
MOLECULES (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
FOXM1 promotes invasion and migration of colorectal cancer cells partially dependent on HSPA5 transactivation
Xiaoyong Luo et al.
ONCOTARGET (2016)
Antiallergic activity of rosmarinic acid esters is modulated by hydrophobicity, and bulkiness of alkyl side chain
Fengxian Zhu et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2015)
Targeting FOXM1 auto-regulation in cancer
Andrei L. Gartel
CANCER BIOLOGY & THERAPY (2015)
Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression
Carter J. Barger et al.
ONCOTARGET (2015)
Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample
Kate E. Brain et al.
BMC CANCER (2014)
FOXM1 Promotes the Warburg Effect and Pancreatic Cancer Progression via Transactivation of LDHA Expression
Jiujie Cui et al.
CLINICAL CANCER RESEARCH (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer
Ning Wen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer
Jinhua Zhou et al.
PLOS ONE (2014)
Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance
Fung Zhao et al.
PLOS ONE (2014)
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Edward Y. Chen et al.
BMC BIOINFORMATICS (2013)
Rosmarinic Acid and Its Methyl Ester as Antimicrobial Components of the Hydromethanolic Extract of Hyptis atrorubens Poit. (Lamiaceae)
Amin Abedini et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
The Forkhead Transcription Factor FOXM1 Controls Cell Cycle-Dependent Gene Expression through an Atypical Chromatin Binding Mechanism
Xi Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients
Yu Wang et al.
LUNG CANCER (2013)
Upregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells
Tomoko Okada et al.
SCIENTIFIC REPORTS (2013)
Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane
Huaping Chen et al.
JOURNAL OF ONCOLOGY (2013)
FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer
Shan-yang He et al.
GYNECOLOGIC ONCOLOGY (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
Ding-Wu Shen et al.
PHARMACOLOGICAL REVIEWS (2012)
FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
Nu Zhang et al.
CANCER CELL (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
Cisplatin resistance: Preclinical findings and clinical implications
Beate Koeberle et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2010)
The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia
Satoki Nakamura et al.
CARCINOGENESIS (2010)
Antioxidant and antimelanogenic properties of rosmarinic acid methyl ester from Origanum vulgare
Hsiou-Yu Ding et al.
FOOD CHEMISTRY (2010)
FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
Jimmy M. -M. Kwok et al.
MOLECULAR CANCER RESEARCH (2010)
A novel mode of FoxM1 regulation Positive auto-regulatory loop
Marianna Halasi et al.
CELL CYCLE (2009)
Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer
Nuran Bektas et al.
BMC CANCER (2008)
FoxM1 inhibitors as potential anticancer drugs
Andrei L. Gartel
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness
I-Ching Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
FOXM1, a typical proliferation-associated transcription factor
Inken Wierstra et al.
BIOLOGICAL CHEMISTRY (2007)
FoxM1 is required for execution of the mitotic programme and chromosome stability
J Laoukili et al.
NATURE CELL BIOLOGY (2005)
Share Paper
